Conditioning regimens for marrow grafting.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000031:analogs & derivatives / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D006082:Graft Enhancement, Immunologic; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000517:prevention & control; D006648:Histocompatibility; D006789:Host vs Graft Reaction; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008214:Lymphocytes / Q000276:immunology; D014916:Whole-Body Irradiation
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents; C002037:dimethylmyleran; D003520:Cyclophosphamide; D002066:Busulfan